Cargando…
Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity
(1) Background: Proprotein convertase subtilisin/kexin 9 (PCSK9) is responsible for the degradation of the hepatic low-density lipoprotein receptor (LDLR), which regulates the circulating cholesterol level. In this field, we discovered natural peptides derived from lupin that showed PCSK9 inhibitory...
Autores principales: | Lammi, Carmen, Fassi, Enrico M. A., Li, Jianqiang, Bartolomei, Martina, Benigno, Giulia, Roda, Gabriella, Arnoldi, Anna, Grazioso, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951016/ https://www.ncbi.nlm.nih.gov/pubmed/35336039 http://dx.doi.org/10.3390/pharmaceutics14030665 |
Ejemplares similares
-
Computational
Design, Synthesis, and Biological Evaluation
of Diimidazole Analogues Endowed with Dual PCSK9/HMG-CoAR-Inhibiting
Activity
por: Lammi, Carmen, et al.
Publicado: (2023) -
Lupin Peptides Modulate the Protein-Protein Interaction of PCSK9 with the Low Density Lipoprotein Receptor in HepG2 Cells
por: Lammi, Carmen, et al.
Publicado: (2016) -
Severe Anti-HMG-CoAR Necrotizing Autoimmune Myopathy Secondary to Statin Use
por: Pulipati, Priyanjali, et al.
Publicado: (2022) -
Biological Characterization of Computationally Designed Analogs of peptide TVFTSWEEYLDWV (Pep2-8) with Increased PCSK9 Antagonistic Activity
por: Lammi, Carmen, et al.
Publicado: (2019) -
Trans-Epithelial Transport, Metabolism, and Biological Activity Assessment of the Multi-Target Lupin Peptide LILPKHSDAD (P5) and Its Metabolite LPKHSDAD (P5-Met)
por: Lammi, Carmen, et al.
Publicado: (2021)